The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors

Low expression of ligands for NK cell-activating receptors contributes to neuroblastoma (NB) aggressiveness. Recently, we demonstrated that the expression of MYCN, a poor prognosis marker in NB, inversely correlates with that of activating ligands. This indicates that MYCN expression level can predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Veneziani, Irene, Fruci, Doriana, Compagnone, Mirco, Pistoia, Vito, Rossi, Paolo, Cifaldi, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481332/
https://www.ncbi.nlm.nih.gov/pubmed/31040907
http://dx.doi.org/10.18632/oncotarget.26736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481332/
https://www.ncbi.nlm.nih.gov/pubmed/31040907
http://dx.doi.org/10.18632/oncotarget.26736

Ejemplares similares